Yinzhihuang oral liquid in the treatment of neonatal jaundice: a meta-analysis

References

• Abu-Ekteish F, Daoud A, Rimawi H, Kakish K, Abu-Heija A. 2000. Neonatal exchange transfusion: a Jordanian experience. Ann Trop Paediatr. 20:57–60.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. 2004. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 114:297–316.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Johnson LH, Keren R. 2004. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am. 51:843–861.
   PubMed Web of Science ®Google Scholar
• Brites D. 2012. The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol. 3:88. doi: 10.3389/fphar.2012.00088.
   PubMed Web of Science ®Google Scholar
• Bryla DA. 1985. Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Development, design, and sample composition. Pediatrics. 75:387–392.
   PubMed Web of Science ®Google Scholar
• Burns JJ. 1964. Implications of enzyme induction for drug therapy. Am J Med. 37:327–331.
   PubMed Web of Science ®Google Scholar
• Chen HF, Yang JH. 2013. Observation of therapeutic effect of Yinzhihuang oral liquid in the treatment of neonatal hyperbilirubinemia 69 cases. Proc Clin Med. 22:254–255.
   Google Scholar
• Chen HY. 2013. Clinical analysis of Yinzhihuang oral liquid in treatment of neonatal jaundice. Chin Community Doct. 15:208–209.
   Google Scholar
• Chinese Pharmacopoeia Committee. 2010. Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science and Technology Press. pp. 871.
   Google Scholar
• Conney AH. 1967. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 19:317–366.
   PubMed Web of Science ®Google Scholar
• Dennery PA, Seidman DS, Stevenson DK. 2001. Neonatal hyperbilirubinemia. N Engl J Med. 344:581–590.
   PubMed Web of Science ®Google Scholar
• Dikshit SK, Gupta PK. 1989. Exchange transfusion in neonatal hyperbilirubinemia. Indian Pediatr. 26:1139–1145.
   PubMedGoogle Scholar
• Fouts JR. 1964. Drug interactions: effects of drugs and chemicals on drug metabolism. Gastroenterology. 46:486–490.
   PubMed Web of Science ®Google Scholar
• Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD, Wennberg RP. 2011. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 128:e925–e931.
   PubMed Web of Science ®Google Scholar
• Gao HW. 2011. Yinzhihuang oral liquid in treatment of neonatal jaundice. Chin Prac Med. 6:175–176.
   Google Scholar
• Guaran RL, Drew JH, Watkins AM. 1992. Jaundice: clinical practice in 88,000 liveborn infants. Aust N Z J Obstet Gynaecol. 32:186–192.
   PubMed Web of Science ®Google Scholar
• Guo XL. 2013. Efficacy obsercation on treatment 98 cases of jaundice of full-term neonatus in the integrative medicine. Clin J Chin Med. 5:12–13.
   Google Scholar
• Hussain B, Korejo GR, Bhurgri S. 2010. Risk factors for kernicterus in neonatal jaundice. Gomal J Med Sci. 8:12–15.
   Google Scholar
• Jiang QM. 2011. Clinical observation on efficacy of Yinzhihuang oral liquid in treatment of 150 cases of neonatal jaundice. Chin J Clin Rat Drug Use. 4:74–75.
   Google Scholar
• Johnson LH, Bhutani VK, Brown AK. 2002 . System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 140:396–403.
   PubMed Web of Science ®Google Scholar
• Kitchen WH. 1970. Neonatal mortality in infants receiving an exchange transfusion. Aust Paediatr J. 6:30–40.
   PubMedGoogle Scholar
• Levin GE, McMullin GP, Mobarak AN. 1970. Controlled trial of phenobarbitone in neonatal jaundice. Arch Dis Child. 45:93–96.
   PubMed Web of Science ®Google Scholar
• Liang LL. 2014. The prognostic analysis on early treatment of neonatal jaundice. Med Info 27:142–143.
   Google Scholar
• Lin Y, Cui CR. 2011. Clinical observation on Yinzhihuang oral liquid in treatment of 64 cases of neonatal jaundice. Chin Com Med. 13:195.
   Google Scholar
• Liu J, Mu YP, Wei ZZ. 2013. Efficacy observation of Yinzhihuang oral liquid in treatment of neonatal uncombined hyperbilirubinemia. Chin Pediatr Integr Tradit West Med. 5:57–58.
   Google Scholar
• Normile D. 2003. Asian medicine. The new face of traditional Chinese medicine. Science. 299:188–190.
   PubMed Web of Science ®Google Scholar
• Mishra S, Agarwal R, Deorari AK, Paul VK 2008. Jaundice in the newborns. Indian J Pediatr. 75:157–163.
   PubMed Web of Science ®Google Scholar
• Mu J, Li J, Sun JR. 2015. Observation of therapeutic effect of Yinzhihuang oral liquid in the treatment of neonatal jaundice. J Liaoning Univ TCM. 17:175–177.
   Google Scholar
• Mwaniki MK, Atieno M, Lawn JE, Newton CR. 2012. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet. 379:445–452.
   PubMed Web of Science ®Google Scholar
• Panagopoulos G, Valaes T, Doxiadis SA. 1969. Morbidity and mortality related to exchange transfusions. J Pediatr. 74:247–254.
   PubMed Web of Science ®Google Scholar
• Qian JQ, Ling WL, Zhou JF. 2014. Clinical observation on efficacy of Yinzhihuang oral liquid in treatment of 82 cases of neonatal hyperbilirubinemia. Chin Pediatr Integr Tradit West Med. 6:536–538.
   Google Scholar
• Qiu J, Wang CM. 2014. Clinical efficacy assessment of Yinzhihuang oral liquid in treatment of neonatal jaundice. Chin J Healthy Brith Child Care. 20:199–200.
   Google Scholar
• Rennie J, Burman-Roy S, Murphy MS, Guideline Development Group. 2010. Neonatal jaundice: summary of NICE guidance. BMJ. 340:c2409.
   PubMed Web of Science ®Google Scholar
• Sgro M, Campbell D, Shah V. 2006. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 175:587–590.
   PubMed Web of Science ®Google Scholar
• Shao MX, Li MK. 2013. Clinical observation on efficacy of Yinzhihuang oral liquid in treatment of neonatal jaundice. Chin Health Care Nutr. 5:409–410.
   Google Scholar
• Trolle D. 1968. Decrease of total serum-bilirubin concentration in newborn infants after phenobarbitone treatment. Lancet. 292:705–708.
   Google Scholar
• Wang SH, Gu ZQ, Yang C, Ma HY. 2010. Clinical Observation on Yinzhihuang oral liquid in treatment of neonatal jaundice. Chin Pediatr Integr Tradit West Med. 2:343–344.
   Google Scholar
• Wang Z, Su B. 2015. Clinical effect of Yinzhihuang oral liquid as adjuvant therapy for neonatal jaundice. J Pediatr Pharm 21:26–28.
   Google Scholar
• Xiang HY. 2014. Treatment of 123 cases of neonatal jaundice by Yinzhihuang oral liquid. Chin Med Mod Dist Educ Chin. 19:35–37.
   Google Scholar
• Xue T, Roy R. 2003. Studying traditional Chinese medicine. Science. 300:740–741.
   PubMed Web of Science ®Google Scholar
• Xv Z. 2011. Clinical observation on efficacy of Yinzhihuang oral liquid in treatment of 60 cases of neonatal jaundice. Chin Manipula Rehabilita Med. 8:123.
   Google Scholar
• Yang GS, Ren MC. 2011. Observation of therapeutic effect of Yinzhihuang oral liquid in the treatment of neonatal jaundice. Jilin Med. 32:6139–6140.
   Google Scholar
• Yan YY, Ye GY. 2014. Clinical observation on efficacy of Yinzhihuang oral liquid in treatment of term newborns with hyperbilirubinemia. Zhejiang J Integr Tradit Chin West Med. 24:251–252.
   Google Scholar
• Yu YT, T J, Zhou XL, He ZK. 2013. Clinical observation of Yinzhihuang oral liquid in treatment of 102 cases of neonatal jaundice. Guiding J Tradit Chin Med Pharm. 19:35–37.
   Google Scholar
• Zhang YS. 2014. Clinical analysis of Yinzhihuang oral liquid in the treatment of 123 cases of neonatal jaundice. Chin Community Doct. 39:94–95.
   Google Scholar
• Zhao S, Wang FY, Zhang AP. 2014. Clinical observation on efficacy of Yinzhihuang oral liquid in treatment of neonatal jaundice. J Medical Forum. 35:26–27.
   Google Scholar
• Zhu Y. 2014. Traditional Chinese medicine combined with western medicine treatment of neonatal jaundice 40 cases. Forum Tradit Chin Med. 29:54–55.
   Google Scholar